126 related articles for article (PubMed ID: 12121239)
41. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
König J; Rost D; Cui Y; Keppler D
Hepatology; 1999 Apr; 29(4):1156-63. PubMed ID: 10094960
[TBL] [Abstract][Full Text] [Related]
42. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition.
Gerk PM; Vore M
J Pharmacol Exp Ther; 2002 Aug; 302(2):407-15. PubMed ID: 12130697
[TBL] [Abstract][Full Text] [Related]
43. A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3.
Connolly L; Moran E; Larkin A; Scheffer G; Scheper R; Sarkadi B; Kool M; Clynes M
Hybrid Hybridomics; 2001; 20(5-6):333-41. PubMed ID: 11839251
[TBL] [Abstract][Full Text] [Related]
44. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas.
Ouban A; Muraca P; Yeatman T; Coppola D
Hum Pathol; 2003 Aug; 34(8):803-8. PubMed ID: 14506643
[TBL] [Abstract][Full Text] [Related]
45. [Effects of MRP2-GSH cotransport system on hepatic arsenic metabolism in rats].
Gao Y; Pei QL; Li GX; Han G; Tian FJ; Qin XJ; Zhang R; Hou WS; Li XY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):278-80. PubMed ID: 16737587
[TBL] [Abstract][Full Text] [Related]
46. Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR.
Lacueva J; Perez-Ramos M; Soto JL; Oliver I; Andrada E; Medrano J; Perez-Vazquez T; Arroyo A; Carrato A; Ferragut JA; Calpena R
Histopathology; 2005 Apr; 46(4):389-95. PubMed ID: 15810950
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
Stöckel B; König J; Nies AT; Cui Y; Brom M; Keppler D
Eur J Biochem; 2000 Mar; 267(5):1347-58. PubMed ID: 10691972
[TBL] [Abstract][Full Text] [Related]
48. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
[TBL] [Abstract][Full Text] [Related]
49. Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
Ferguson RE; Jackson SM; Stanley AJ; Joyce AD; Harnden P; Morrison EE; Patel PM; Phillips RM; Selby PJ; Banks RE
Int J Cancer; 2005 May; 115(1):155-63. PubMed ID: 15645438
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells.
Kubitz R; Huth C; Schmitt M; Horbach A; Kullak-Ublick G; Häussinger D
Hepatology; 2001 Aug; 34(2):340-50. PubMed ID: 11481619
[TBL] [Abstract][Full Text] [Related]
51. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality.
Netsch MI; Gutmann H; Luescher S; Brill S; Schmidlin CB; Kreuter MH; Drewe J
Planta Med; 2005 Feb; 71(2):135-41. PubMed ID: 15729621
[TBL] [Abstract][Full Text] [Related]
53. Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases.
Kojima H; Sakurai S; Uemura M; Kitamura K; Kanno H; Nakai Y; Fukui H
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e120-8. PubMed ID: 17725603
[TBL] [Abstract][Full Text] [Related]
54. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR
J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900
[TBL] [Abstract][Full Text] [Related]
55. Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity.
Smitherman PK; Townsend AJ; Kute TE; Morrow CS
J Pharmacol Exp Ther; 2004 Jan; 308(1):260-7. PubMed ID: 14569069
[TBL] [Abstract][Full Text] [Related]
56. SIRT1-mediated FoxO1 deacetylation is essential for multidrug resistance-associated protein 2 expression in tamoxifen-resistant breast cancer cells.
Choi HK; Cho KB; Phuong NT; Han CY; Han HK; Hien TT; Choi HS; Kang KW
Mol Pharm; 2013 Jul; 10(7):2517-27. PubMed ID: 23763570
[TBL] [Abstract][Full Text] [Related]
57. Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites.
Kauffmann HM; Vorderstemann B; Schrenk D
Toxicology; 2001 Oct; 167(1):25-35. PubMed ID: 11557127
[TBL] [Abstract][Full Text] [Related]
58. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
[TBL] [Abstract][Full Text] [Related]
59. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.
Bakos E; Evers R; Sinkó E; Váradi A; Borst P; Sarkadi B
Mol Pharmacol; 2000 Apr; 57(4):760-8. PubMed ID: 10727523
[TBL] [Abstract][Full Text] [Related]
60. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2.
Leier I; Hummel-Eisenbeiss J; Cui Y; Keppler D
Kidney Int; 2000 Apr; 57(4):1636-42. PubMed ID: 10760098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
